Smith & Nephew falls after downgrade by leading investment bank
Shares in Smith & Nephew PLC (LSE:SN) fell 2% after UBS downgraded stock in the med-tech firm to 'neutral' from 'buy' on valuation grounds. The price target remains at £12.50. The downgrade reflects concerns over limited near-term …